FDA Inspection 1060719 — Interfarma Corp.

Interfarma Corp. — FEI 3003605812

The FDA completed an inspection of Interfarma Corp. on Jul 25, 2018 in Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 7 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 25, 2018
Fiscal Year
2018
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Miami, FL (United States)

Citations

IDCFRDescription
1561921 CFR 111.180(b)(1)Written procedures - packaging, labeling received
1564121 CFR 111.453Written procedures - holding
1579021 CFR 111.403Written procedures - labeling operations
1579121 CFR 111.403Written procedures -packaging operations
1579721 CFR 111.553Written procedures - product complaint
1592721 CFR 111.103Written procedures - quality control operations
1604221 CFR 111.503Written procedures - returned dietary supplement